PD14-01 ONCE-DAILY VIBEGRON, A NOVEL ORAL β 3 AGONIST DOES NOT INHIBIT CYP2D6, A COMMON PATHWAY FOR DRUG METABOLISM IN PATIENTS ON OAB MEDICATIONS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.